Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Amyris Inc AMRSQ

Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (GREY:AMRSQ)

No current opinion is available.

Bullboard Posts (GREY:AMRSQ)

AMYRIS: REINVENTING THE BEAUTY AND PERSONAL CARE INDUSTRY

$AMRS We are excited to share an article about Amyris Inc. (NASDAQ: AMRX), a synthetic biotechnology company known for its...
AviseAnalytics - March 30, 2023

New SeekingAlpha Article:"Amyris:Surviving the Perfect Storm

New comprehensive and forward-looking article just published on SeekingAlpha https://seekingalpha.com/.../4484181-amyris-surviving......
jthottam - February 3, 2022

Answer to a Yahoo Question on AMRS Share Price

I thought this would be helpful for everyone but is in response to Jan R.'s question about "I need AMRS to reach $25 to become...
jthottam - December 22, 2021

Update from ImmunityBio (includes information on AMRS JV)

Update: Amyris (Ticker: AMRS)   The following press release today (December 20th, 2021) from ImmunityBio (Ticker...
jthottam - December 20, 2021

IDRI Contract with BARDA (potential opportunity for AMRS)

Update: Amyris (Ticker: AMRS)   The following was published by Infection Disease Research Institue ("IDRI"...
jthottam - December 18, 2021

Status Update on IBRX and AMRS

The following is a recent CNN video of an interview of the Chairman of ImmunityBio (Ticker: IBRX) Patrick Soon-Shiong who is in a joint...
jthottam - December 16, 2021